Youngy Health Co., Ltd.
Symbool: 300247.SZ
SHZ
2.97
CNYMarktprijs vandaag
68.1562
Koers/Winst Verhouding
4.6551
Koers/Winst Groei Verhouding
2.39B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Youngy Health Co., Ltd. (300247-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 493.1 | 409.3 | 235.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 374 | 341 | 144.3 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 51.8 | 54.3 | 65.6 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 143.9 | 186.6 | 149.2 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 129.2 | 116.5 | 51 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 818 | 766.7 | 501.4 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 224.9 | 246.1 | 259.4 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 42.8 | 44.9 | 55.5 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 42.8 | 44.9 | 55.5 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | -323 | -290.1 | -10.9 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 7 | 3.1 | 1.9 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 451.9 | 416.1 | 214.7 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 403.5 | 420.1 | 520.7 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1221.6 | 1186.8 | 1022.2 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 47.4 | 52.7 | 52 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 12 | 10.4 | 7 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 2.7 | 3.6 | 2.7 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5.4 | 17 | 25.1 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | -19.1 | -15.9 | 0.1 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 1.7 | 2.4 | 1.9 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 24.5 | 32.9 | 33.2 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5.4 | 17 | 25.1 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 148.9 | 158 | 161.1 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 804 | 804 | 804 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1200.1 | -1226.7 | -1353 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 45.1 | 66.5 | 35.3 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1367.7 | 1345.1 | 1345.1 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1016.8 | 989 | 831.4 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1221.6 | 1186.8 | 1022.2 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 55.9 | 39.8 | 29.7 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1072.7 | 1028.8 | 861.1 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 50.9 | 50.9 | 133.4 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 17.3 | 27.4 | 32.1 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | -101.8 | -40.9 | -59.2 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 133.3 | 31.4 | -55.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 28.4 | 22.6 | 18.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 6.7 | 1.9 | 1.1 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -6.7 | -1.9 | -1.1 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -51.9 | -18.9 | 75.4 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | -14.7 | 15.9 | 24.1 | |||||||||||||||||
cash-flows.row.inventory | 0 | -40 | -44 | 3.2 | |||||||||||||||||
cash-flows.row.account-payables | 0 | -3.9 | 7.4 | 47 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 6.7 | 1.9 | 1.1 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -139.1 | -24.3 | 42.3 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -17.5 | -6.2 | -8.7 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.2 | 0.2 | 35.5 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -800.7 | -374.7 | -355.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 805.5 | 256.5 | 368.4 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 19.1 | 55 | 0.5 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 7.6 | -69.3 | 39.8 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -11.6 | -5.7 | -25 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.9 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -11.6 | -5.7 | -10.8 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -11.6 | -5.7 | -36.7 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 10.1 | -4.5 | -10.1 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -23 | -68.7 | 73.9 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 68.3 | 91.3 | 160 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 91.3 | 160 | 86.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -29.2 | 10.8 | 81 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -17.5 | -6.2 | -8.7 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -46.7 | 4.6 | 72.3 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 529.4 | 463.3 | 526.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 355.5 | 352 | 399.3 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 174 | 111.3 | 127.2 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 13.7 | 4 | 15.3 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 132.2 | 119.2 | 112.2 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 487.6 | 471.2 | 511.5 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 7.9 | 2.9 | 2.5 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0.6 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 0.3 | -0.8 | -0.5 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 13.7 | 4 | 15.3 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 0.3 | -0.8 | -0.5 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0.6 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 28 | 28.4 | 22.6 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | 59.4 | 137.2 | 38.3 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 59.8 | 136.4 | 37.8 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 17.8 | 3.1 | 6.3 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | 26.6 | 126.3 | 24.2 |
Vaak gestelde vragen
Wat is Youngy Health Co., Ltd. (300247.SZ) totale activa?
Youngy Health Co., Ltd. (300247.SZ) totale activa is 1221559067.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.332.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.066.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.130.
Wat is Youngy Health Co., Ltd. (300247.SZ) nettowinst (netto-inkomen)?
De nettowinst is 26582643.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 17332369.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 132173058.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.